A Better
Tomorrow
For People Living with Rare Genetic Epilepsies
Powered by a highly predictive genetic screening platform, Epygenix is a clinical stage biopharmaceutical company focused on developing treatments for rare and intractable genetic epilepsies.
Get informed when we launch our new website: